Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Niraparib market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Niraparibmarket, defines the market attractiveness level of Niraparib market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Niraparib industry, describes the types of Niraparib market, the applications of major players and the market size, and deeply analyzes the current situation of the global Niraparib market and the development prospects and opportunities of Niraparib industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Niraparib market in Chapter 13.
By Player:
Everest Pharmaceuticals Limited
TESARO
By Type:
100mg*30 Capsules
100mg*60 Capsules
100mg*90 Capsules
By End-User:
Recurrent Epithelial Ovarian Cancer
Fallopian Tube Cancer
Primary Peritoneal Cancer
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Niraparib Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Niraparib Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Niraparib Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Niraparib Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Niraparib Market Analysis and Outlook to 2022
-
7.1 Global Niraparib Consumption (2017-2022)
-
7.2 United States Niraparib Consumption (2017-2022)
-
7.3 Europe Niraparib Consumption (2017-2022)
-
7.4 China Niraparib Consumption (2017-2022)
-
7.5 Japan Niraparib Consumption (2017-2022)
-
7.6 India Niraparib Consumption (2017-2022)
-
7.7 South Korea Niraparib Consumption (2017-2022)
8 Region and Country-wise Niraparib Market Analysis and Outlook to 2028
-
8.1 Global Niraparib Consumption Forecast (2022-2028)
-
8.2 United States Niraparib Consumption Forecast (2022-2028)
-
8.3 Europe Niraparib Consumption Forecast (2022-2028)
-
8.4 China Niraparib Consumption Forecast (2022-2028)
-
8.5 Japan Niraparib Consumption Forecast (2022-2028)
-
8.6 India Niraparib Consumption Forecast (2022-2028)
-
8.7 South Korea Niraparib Consumption Forecast (2022-2028)
9 Global Niraparib Market Outlook by Types and Applications to 2022
-
9.1 Global Niraparib Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 100mg*30 Capsules Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 100mg*60 Capsules Consumption and Growth Rate (2017-2022)
-
9.1.3 Global 100mg*90 Capsules Consumption and Growth Rate (2017-2022)
-
9.2 Global Niraparib Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Recurrent Epithelial Ovarian Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Fallopian Tube Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Primary Peritoneal Cancer Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Global Niraparib Market Outlook by Types and Applications to 2028
-
10.1 Global Niraparib Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global 100mg*30 Capsules Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global 100mg*60 Capsules Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global 100mg*90 Capsules Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Niraparib Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Recurrent Epithelial Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Fallopian Tube Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Primary Peritoneal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Niraparib Import and Export Analysis (Top 5 Countries)
-
11.1 Global Niraparib Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Niraparib Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Niraparib Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Niraparib Market Competitive Analysis
-
14.1 Everest Pharmaceuticals Limited
-
14.1.1 Everest Pharmaceuticals Limited Company Details
-
14.1.2 Everest Pharmaceuticals Limited Niraparib Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Everest Pharmaceuticals Limited Niraparib Product and Service
-
14.2 TESARO
-
14.2.1 TESARO Company Details
-
14.2.2 TESARO Niraparib Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 TESARO Niraparib Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Niraparib
-
Figure Niraparib Picture
-
Table Global Niraparib Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Niraparib Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Niraparib Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Niraparib Consumption by Country (2017-2022)
-
Figure United States Niraparib Consumption and Growth Rate (2017-2022)
-
Table Europe Niraparib Consumption and Growth Rate (2017-2022)
-
Figure China Niraparib Consumption and Growth Rate (2017-2022)
-
Figure Japan Niraparib Consumption and Growth Rate (2017-2022)
-
Figure India Niraparib Consumption and Growth Rate (2017-2022)
-
Figure South Korea Niraparib Consumption and Growth Rate (2017-2022)
-
Figure Global Niraparib Consumption Forecast by Country (2022-2028)
-
Figure United States Niraparib Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Niraparib Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Niraparib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Niraparib Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Niraparib Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Niraparib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 100mg*30 Capsules Consumption and Growth Rate (2017-2022)
-
Figure Global 100mg*60 Capsules Consumption and Growth Rate (2017-2022)
-
Figure Global 100mg*90 Capsules Consumption and Growth Rate (2017-2022)
-
Figure Global Recurrent Epithelial Ovarian Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Fallopian Tube Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Primary Peritoneal Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global 100mg*30 Capsules Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 100mg*60 Capsules Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 100mg*90 Capsules Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Recurrent Epithelial Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Fallopian Tube Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Primary Peritoneal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Niraparib Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Niraparib Export by Region (Top 5 Countries) (2017-2028)
-
Table Everest Pharmaceuticals Limited (Foundation Year, Company Profile and etc.)
-
Table Everest Pharmaceuticals Limited Niraparib Sales, Price, Value and Gross Profit (2017-2022)
-
Table Everest Pharmaceuticals Limited Niraparib Product and Service
-
Table TESARO (Foundation Year, Company Profile and etc.)
-
Table TESARO Niraparib Sales, Price, Value and Gross Profit (2017-2022)
-
Table TESARO Niraparib Product and Service
-
